Search results for: 'injection technologies'

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injectables, intravenous injectables, intramuscular injectables, and others. Major market challenges,...

In almost all parts of the world, women live longer than men. The exact cause behind the differential between male and female life expectancy is uncertain, but it appears to be partly explained by biological advantages and partly by environmental and behavioral factors. However, as women outlive men, they are more prone to suffering from ill healt...

Bionic devices are mechatronic or electronic platforms that can perform the physical and biological functions of body parts or organs that are lost or damaged because of chronic conditions or accidents. Patients that suffer complete vision loss because of retinal diseases; upper and lower limb amputations caused by accidents or chronic diseases; an...

Orthopedic implants replace or strengthen a damaged, painful, or deformed bone, cartilage, or joint and restore mobility and flexibility in patients with bone conditions. The demand for orthopedic implants is growing with the increasing number of orthopedic surgeries being performed every year. This is mainly due to the prevalence of musculoskeleta...

This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...

Emerging endoscopy technologies leverage advanced surgical visualization and instrumentation techniques during the pre-operative and intraoperative phases of surgical procedures. The use of these techniques helps surgeons to clearly visualize, accurately identify, and localize anomalies, and subsequently navigate and perform complex surgeries with ...

Smart implants are medical devices that incorporate sensors, electronics, and wireless communication technologies to provide unprecedented diagnostic and therapeutic capabilities. In this report, Frost & Sullivan analyzes smart implants with monitoring capabilities that can track different implant types and provide patient health data to clinicia...

The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countr...